The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter

被引：37

作者：

Lowe, John A., III ^{[1
]}

Hou, Xinjun ^{[1
]}

Schmidt, Christopher ^{[1
]}

Tingley, F. David, III ^{[1
]}

McHardy, Stan ^{[1
]}

Kalman, Monica ^{[1
]}

DeNinno, Shari ^{[1
]}

Sanner, Mark ^{[1
]}

Ward, Karen ^{[1
]}

Lebel, Lorraine ^{[1
]}

Tunucci, Don ^{[1
]}

Valentine, James ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Groton, CT 06340 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 11期

关键词：

Glycine; Transporter; Inhibitor; 3.1.0]-Azabicyclic; Schizophrenia; NMDA;

D O I：

10.1016/j.bmcl.2009.04.035

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The type 1 glycine transporter plays an important in regulating homeostatic glycine levels in the brain that are relevant to the activation of the NMDA receptor by the excitatory neurotransmitter glutamate. We describe herein the structure-activity relationships (SAR) of a structurally novel class of GlyT1 inhibitors following on a lead derived from high throughput screening, which shows good selectivity for GlyT1 and potent activity in elevating CSF levels of glycine. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：2974 / 2976

页数：3

共 50 条

[41] Characterization of multiple forms of the human glycine transporter type-2
Gallagher, MJ
Burgess, LH
Brunden, KR
MOLECULAR BRAIN RESEARCH, 1999, 70 (01): : 101 - 115
[42] Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability
Alberati, Daniela
Hainzl, Dominik
Jolidon, Synese
Krafft, Eva A.
Kurt, Anke
Maier, Axel
Pinard, Emmanuel
Thomas, Andrew W.
Zimmerli, Daniel
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4311 - 4315
[43] Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)
Chue, Pierre
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (07) : 1311 - 1320
[44] Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice
Singer, Philipp
Boison, Detlev
Moehler, Hanns
Feldon, Joram
Yee, Benjamin K.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 (05) : 401 - 413
[45] Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1
Varnes, Jeffrey G.
Forst, Janet M.
Hoerter, Tiffany N.
Holmquist, Christopher R.
Wilkins, Deidre E.
Tian, Gaochao
Jonak, Gerald
Wang, Xia
Potts, William M.
Wood, Michael W.
Alhambra, Cristobal
Brugel, Todd A.
Albert, Jeffrey S.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (16) : 4878 - 4881
[46] Pharmacological characterisation of the GlyT-1 glycine transporter using two novel radioligands
Herdon, Hugh J.
Roberts, Jennifer C.
Coulton, Steve
Porter, Rod A.
NEUROPHARMACOLOGY, 2010, 59 (06) : 558 - 565
[47] Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans
Wong, Dean F.
Ostrowitzki, Susanne
Zhou, Yun
Raymont, Vanessa
Hofmann, Carsten
Borroni, Edilio
Kumar, Anil
Parkar, Nikhat
Brasic, James R.
Hilton, John
Dannals, Robert F.
Martin-Facklam, Meret
NEUROIMAGE, 2013, 75 : 282 - 290
[48] Discovery and SAR studies of novel GlyT1 inhibitors
Walter, Magnus W.
Hoffman, Beth J.
Gordon, Kimberly
Johnson, Kirk
Love, Patrick
Jones, Matthew
Man, Teresa
Phebus, Lee
Reel, Jon K.
Rudyk, Helene C.
Shannon, Harlan
Svensson, Kjell
Yu, Hong
Valli, Matthew J.
Porter, Warren J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5233 - 5238
[49] Distribution of the glycine transporter glyt-1 in mammalian and nonmammalian retinae
Pow, DV
Hendrickson, AE
VISUAL NEUROSCIENCE, 1999, 16 (02) : 231 - 239
[50] The Glycine Transporter GLYT1 in Human Intestine: Expression and Function
Howard, Alison
Hirst, Barry Hugo
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (06) : 784 - 788

← 1 2 3 4 5 →